Prader-Willi Syndrome clinical trials at UC Irvine

1 in progress, 0 open to eligible people

DCCR in Patients With Prader-Willi Syndrome
Sorry, in progress, not accepting new patients
The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.
Orange, California and other locations

Last updated: March 29, 2024